1620 Beacon Place
About CURE Pharmaceutical
CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), one of the most advanced oral thin film on the market today. CURE is developing an array of products in innovative delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada and Israel. The company's mission is to improve people's lives by redefining how medicines are delivered and experienced.
CEO: Robert Davidson
COO: Jessica Rousset
CFO: Alex Katz
70 articles about CURE Pharmaceutical
CURE Pharma Strengthens Senior Leadership Team With Appointment Of Industry Veteran Richard Serbin As Head Of Global Corporate Development
CURE Pharma Adds Industry Veteran, Anti-Aging Specialist And Medicinal Cannabis Supporter, Alan Einstein, To Its Board Of Directors
CURE Pharma Announces Product Development And Licensing Deal With Diverse International Pharmaceutical Company Meroven, Ltd.
CURE Pharma Announces Research Collaboration With CannaKids To Develop Cannabinoid And Terpene Molecules Using Cure’s Proprietary Delivery Technologies